InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.Earlier this week, pharmaceutical giant Lilly published in the Journal of the American Medical Association the results of its phase 3 trial for donanemab, an antibody treatment for Alzheimer’s. The drug works by removing a protein called beta amyloid from […]
